Cardiff Oncology, Inc. (CRDF)

[pottsvision]

This company has a drug that basically arrests tumor growth... giving existing treatments a better chance of destroying tumors... let that sink in!

Whatever cancer tech comes along - this drug is going to be useful... note how it is testing for *synergies* with existing treatments - the synergies are being proven right now!

Those treatments will come and go - but the drug(s) TROV is working on will remain useful for generations of cancer treatments to come... the sticking point was *safety* of PLK1 inhibition - it looks like TROV has proven safety, well enough that phase 3 is pretty well certain... being that TROV is evolving upon other companies drugs touted as highly effective but carrying bad side effects/that TROV has *resolved*, the pathway from here becomes much more clear (WAY up!).

This is worth *billions*, the price action until buyout is basically irrelevant at this point... not holding till then would likely be most regretful... very true that this thing has been pumped and dumped into oblivion - but in very true biotech fashion we very well could be in the early stages of what will ultimately be a massive windfall.